Modified Somatic Perception Questionnaire

1. Abstract

The Modified Somatic Perception Questionnaire (MSPQ) is a standardized 13-item self-report psychometric instrument developed by Chris J. Main in 1983 to quantify heightened somatic awareness, physiological autonomic arousal, and functional somatic distress in patients presenting with persistent pain syndromes, particularly chronic low back pain and musculoskeletal disorders. Originating as an adaptation of the Somatic Perception Questionnaire (SPQ) formulated by Wilbur and colleagues, the MSPQ isolates autonomic and visceral sensations that are predominantly non-pain symptoms, distinguishing genuine physiological reactivity and central somatic amplification from core nociceptive input. Administered using a four-point Likert scale ranging from 0 (“Not at all”) to 3 (“Extremely / could not have been worse”), the instrument yields a unidimensional composite score spanning from 0 to 39, where elevated scores reflect magnified somatic tracking, psychological distress, and maladaptive illness behavior.

Extensive psychometric investigations have affirmed the MSPQ’s robust internal consistency (Cronbach’s alpha typically ranging from .78 to .88 across orthopedic and multidisciplinary rehabilitation cohorts) and satisfactory test-retest reliability across clinical intervals. Structural validity assessments, comprising both exploratory and confirmatory factor analyses, validate a predominant single-factor structure reflecting generalized somatic and autonomic hypervigilance. When utilized within clinical decision algorithms alongside the Beck Depression Inventory or the Distress and Risk Assessment Method (DRAM), the MSPQ exhibits exceptional predictive validity for chronic disability, prolonged work absenteeism, elevated healthcare utilization, and adverse surgical outcomes following spinal procedures. The instrument remains an essential, parsimonious assessment tool in physical therapy, pain psychology, behavioral medicine, and orthopedic rehabilitation worldwide.

2. Keywords

Modified Somatic Perception Questionnaire, MSPQ, somatic awareness, autonomic arousal, somatization, chronic low back pain, illness behavior, somatic amplification, psychometrics, Distress and Risk Assessment Method

3. Authors

The Modified Somatic Perception Questionnaire was designed and validated by Chris J. Main, PhD, FBPsS, a prominent British clinical and health psychologist known for his foundational contributions to the biopsychosocial model of chronic musculoskeletal pain.

• Primary Author: Chris J. Main, PhD
• Academic Affiliations: Emeritus Professor of Clinical Psychology in Pain Management, Keele University, Staffordshire, United Kingdom; formerly Consultant Clinical Psychologist at the Department of Behavioural Medicine, Hope Hospital (Salford Royal NHS Foundation Trust), University of Manchester, United Kingdom.
• Collaborative Context: Dr. Main formulated the scale within the interdisciplinary spinal research team at the University of Manchester and Hope Hospital, collaborating closely with orthopedic surgeon Gordon Waddell, DSc, MD, FRCS, leading to pioneering paradigms such as Waddell’s nonorganic signs and the Distress and Risk Assessment Method (DRAM).

4. Purpose

The primary clinical and empirical objective of the Modified Somatic Perception Questionnaire is to provide an objective, standardized metric of subjective somatic sensations and autonomic physiological responsiveness that accompany prolonged pain and psychological distress. In individuals afflicted with chronic spinal pain, fibromyalgia, and complex regional pain syndromes, the clinical picture is frequently confounded by nonorganic symptomatology, widespread visceral sensations, and hypervigilant monitoring of autonomic fluctuations. The MSPQ was specifically designed to separate these somatic-affective manifestations from localized musculoskeletal nociception, allowing clinicians to measure the extent of physiological hyper-reactivity without penalizing the patient for focal pain symptoms.

In clinical practice, the MSPQ serves as a screening and risk-stratification mechanism. Elevated scores signal that a patient’s functional disability may be driven not solely by structural spinal pathology, but rather by heightened bodily hypervigilance, autonomic arousal, and somatization. Consequently, spine surgeons and rehabilitation physicians utilize the MSPQ to identify candidates who may experience suboptimal outcomes or prolonged post-operative disability following invasive lumbar interventions, such as spinal fusion or discectomy. Identifying elevated somatic awareness allows the clinical team to integrate targeted cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), autonomic self-regulation (such as biofeedback), and pain neuroscience education prior to or in lieu of surgical procedures.

In empirical research, the MSPQ is extensively employed as a continuous measure of somatic amplification in trials examining pharmacological agents, multimodal rehabilitation programs, interdisciplinary pain management networks, and neuroimaging studies exploring the central sensitization of somatic perception. By isolating functional somatic symptoms from affective-cognitive depressive thoughts, researchers can discern whether therapeutic interventions modulate central nervous system hyperexcitability or purely cognitive appraisal mechanisms.

5. Psychological Construct

The Modified Somatic Perception Questionnaire quantifies the overarching construct of somatic awareness and autonomic hyper-reactivity. This construct encompasses the subjective perception, selective attention toward, and cognitive amplification of normal or mildly heightened physiological autonomic processes. Unlike hypochondriasis or pervasive somatic symptom disorder defined strictly through psychiatric nosology, somatic perception within the chronic pain sphere denotes a dimensional psychophysiological process characterized by central nervous system sensitization, visceral sensations, and elevated autonomic feedback loops.

The items comprising the MSPQ capture three interconnected operational facets of somatic reactivity:

• Sympathetic Autonomic Activation: Symptoms arising from heightened sympathetic nervous system output, such as tachycardia (“Heart rate increasing”), generalized diaphoresis (“Sweating all over”), peripheral or core thermoregulatory shifts (“Feeling hot all over”), and xerostomia (“Mouth becoming dry”).
• Motor-Muscular Tension and Neuromuscular Agitation: Somatic complaints rooted in elevated skeletomotor tone and psychomotor unrest, including nuchal discomfort (“Muscles in neck aching”), motor fasciculations or involuntary spasms (“Muscles twitching or jumping”), cephalic tension (“Tense feeling across forehead”), peripheral weakness (“Legs feeling weak”), gross tremor (“Trembling or shaking”), and kinetic restlessness (“Restless, can’t keep still”; “Rapid walking”).
• Visceral and Enteric Hyperesthesia: Visceral sensory amplification occurring within the gastrointestinal and upper aerodigestive tracts, evidenced by functional dysphagia (“Difficulty in swallowing”) and epigastric/enteric sensations associated with acute anxiety (“Feeling of butterflies in stomach”).

Crucially, the scale omits direct queries regarding primary lumbar, thoracic, or cervical joint pain. By deliberately excluding the primary site of musculoskeletal complaint, the construct exclusively isolates the degree to which an individual experiences generalized physiological arousal and somatic focusing, reflecting a generalized state of bodily distress rather than anatomical impairment.

6. Theoretical Framework

The development of the MSPQ is situated squarely within the theoretical evolution of the biopsychosocial model of medicine, originally articulated by George L. Engel and operationalized in musculoskeletal medicine by Gordon Waddell and Chris J. Main. Prior to the early 1980s, spinal assessment rested almost exclusively upon the biomedical reductionist paradigm, which assumed a direct linear correlation between structural tissue damage (such as disk herniation or degenerative spondylosis) and reported pain and disability. However, clinical discrepancies—such as severe disability in the presence of minimal radiographic changes—necessitated a broader framework.

Main integrated concepts from David Mechanic’s illness behavior theory and Arthur J. Barsky’s conceptualization of somatosensory amplification. Somatosensory amplification posits that individuals vary systematically in their propensity to perceive innocuous or normal somatic visceral sensations as intense, noxious, and threatening. When an individual sustains a painful musculoskeletal injury, heightened anxiety activates the sympathetic branch of the autonomic nervous system. This physiological surge generates palpable bodily sensations, such as tachycardia, sweating, muscle tension, and dry mouth. In individuals characterized by elevated somatic awareness, these visceral sensations are catastrophically misinterpreted as evidence of systemic physical deterioration, which triggers additional anxiety, establishing a self-perpetuating psychophysiological feedback loop.

Furthermore, the MSPQ interfaces with modern central sensitization theory and predictive processing models in cognitive neuroscience. Under these frameworks, chronic pain represents a state of altered sensory gain wherein top-down attentional priors hyper-sensitize subcortical and cortical processing networks (including the insula, anterior cingulate cortex, and amygdala). The MSPQ captures the subjective manifestation of this uncalibrated interoceptive prediction error, reflecting an over-sensitized interoceptive neural circuitry.

7. Validity

Empirical investigations conducted across four decades have established the comprehensive construct, criterion, convergent, and discriminant validity of the MSPQ.

Construct and Convergent Validity

Construct validity was initially confirmed by Main (1983) during the questionnaire’s development. Scores on the MSPQ demonstrate substantial positive correlations with validated inventories measuring psychological distress, anxiety, and depression. Specifically, the MSPQ correlates moderately to strongly with the State-Trait Anxiety Inventory (STAI) (r = .52 to .66), the Beck Depression Inventory (BDI) (r = .48 to .61), and the Minnesota Multiphasic Personality Inventory (MMPI) Hypochondriasis (Hs) and Hysteria (Hy) clinical scales (r = .55 to .70). Notably, the MSPQ exhibits moderate convergent validity with measures of pain catastrophizing, such as the Pain Catastrophizing Scale (PCS) (r = .45 to .58), reflecting the shared cognitive-affective mechanism of threat monitoring.

Discriminant Validity

The scale effectively discriminates between patients exhibiting organic pathology congruent with physical examination findings and those displaying marked nonorganic behavioral responses. In classic investigations by Main and Waddell, patients with high scores on Waddell’s Nonorganic Signs demonstrated significantly elevated MSPQ scores compared to patients with isolated organic findings (p < .001). Furthermore, while the MSPQ correlates moderately with general negative affect, factor analytic studies show that it loads distinctly from pure depressive cognitive items (such as feelings of guilt, hopelessness, and worthlessness), establishing discriminant validity against pure affective-cognitive depression.

Predictive and Criterion Validity

The MSPQ demonstrates prominent predictive utility in prospective orthopedic cohorts. When incorporated into the Distress and Risk Assessment Method (DRAM), an MSPQ score exceeding 12—particularly in combination with elevated depressive symptomatology—predicts poor functional recovery, chronic persistence of back-related disability on the Oswestry Disability Index (ODI), failure to return to work at 12-month follow-up, and dissatisfaction with lumbar surgery outcomes. Conversely, low MSPQ scores (below 6) reliably identify psychologically stable cohorts who demonstrate favorable prognostic outcomes following standard physical rehabilitation.

8. Reliability

The reliability of the Modified Somatic Perception Questionnaire has been evaluated across diverse clinical and experimental environments.

• Internal Consistency: In the original validation by Main (1983) encompassing chronic back pain cohorts, the instrument demonstrated high internal consistency, yielding a Cronbach’s alpha coefficient of .82. Subsequent cross-validation studies across European, North American, and Australasian cohorts have reported alpha coefficients consistently spanning between .78 and .88, confirming high item-scale homogeneity across divergent chronic pain populations.
• Item-Total Correlations: Corrected item-total correlations for all 13 items consistently surpass the acceptable psychometric threshold of .30, with most items ranging from .38 to .64. Items measuring autonomic perspiration, tachycardia, and muscular tremors systematically demonstrate the strongest relationships with the aggregate score.
• Test-Retest Reliability: Test-retest stability was examined across stable chronic pain cohorts across intervals spanning from 24 hours to two weeks. Pearson correlation coefficients and intraclass correlation coefficients (ICC) range from .74 to .89, indicating substantial temporal stability when the underlying clinical condition remains stable.
• Standard Error of Measurement (SEM): The SEM for the MSPQ has been calculated between 1.8 and 2.4 points, providing clinicians with a clear index for evaluating true individual change versus measurement error during clinical monitoring.

9. Factor Analysis

The latent structure of the MSPQ has been scrutinized via both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).

Exploratory Factor Structure

In the foundational principal components analysis conducted by Main (1983), the initial 22-item pool was subjected to orthogonal and oblique rotations. Nine items that exhibited ambiguous cross-loadings, weak discrimination, or direct conflation with focal pain pathology were eliminated, leaving 13 salient clinical items. In the 13-item version, a dominant first factor accounted for the primary variance (approximately 34% to 42% across studies), supporting the operational use of the MSPQ as an essentially unidimensional measure of autonomic and somatic awareness.

Confirmatory Factor Analysis and Multidimensional Models

While commonly applied as a single composite score, several structural investigations (e.g., Greenough & Fraser; Main et al.) have evaluated bifactor or two-factor models parsing the construct into:

1. Autonomic Visceral Activation: Comprising items related to heart rate, sweating, hot flushes, dry mouth, swallowing difficulty, and butterflies in the stomach (loadings ranging from .45 to .76).
2. Musculoskeletal and Motor Agitation: Encompassing items tapping muscle twitching, neck aches, facial tension, tremor, and motor restlessness (loadings ranging from .42 to .72).

Goodness-of-fit evaluations for a single higher-order factor model show acceptable model fit parameters across clinical cohorts: Comparative Fit Index (CFI) > .92, Tucker-Lewis Index (TLI) > .90, and Root Mean Square Error of Approximation (RMSEA) between .054 and .072. These metrics endorse the clinical standard of summing all 13 items into a single dimensional index representing overall somatic hypervigilance.

10. Instrument / Measurement Tool

• Instrument Type: Self-administered psychometric questionnaire / Clinical rating inventory
• Construct Assessed: Heightened somatic perception, autonomic arousal, and somatosensory amplification
• Target Demographics: Adult patients (18–65+ years) presenting with chronic musculoskeletal disorders, low back pain, cervical spine dysfunction, or persistent non-malignant pain syndromes
• Administration Format: Paper-and-pencil or secure computer/digital administration
• Completion Time: Approximately 2 to 4 minutes
• Number of Items: 13 clinically scored items (derived from an original 22-item research pool that incorporated 9 un-scored filler items)
• Response Scale: 4-point Likert scale:
  • 0 = Not at all
  • 1 = A little / slightly
  • 2 = A great deal / quite a bit
  • 3 = Extremely / could not have been worse
• Scoring and Quantification:
  • Items are scored directly from 0 to 3 based on patient endorsement.
  • There are no reverse-scored items.
  • The total score is calculated by summing the responses across all 13 items: Total Score = ∑(Items 1 through 13).
  • Score Range: 0 to 39.
• Clinical Cut-Offs & Interpretation:
  • 0 to 5: Normal / Low somatic awareness. Somatic reporting is within typical physiological parameters; psychological distress is negligible.
  • 6 to 12: Moderate somatic awareness. Indicates emerging somatic hypervigilance; clinically monitored in conjunction with mood assessments.
  • > 12: Elevated somatic awareness / Marked somatization. Strong marker of psychophysiological distress and heightened illness behavior. When combined with elevated depression scores on the DRAM, patients are classified as “Distressed Somatizers”, carrying increased risk of prolonged disability and diminished surgical efficacy.

11. Permissions & Fee and Test Year

The Modified Somatic Perception Questionnaire was first published in 1983 by Dr. Chris J. Main in the Journal of Psychosomatic Research. As an academic psychometric measure published within the scientific literature, the instrument is generally accessible for non-commercial academic research, public health tracking, and routine clinical evaluation without royalty fees, provided proper formal academic citation is maintained.

For commercial integration into proprietary clinical software, enterprise digital health platforms, or sponsored pharmacological trials, users must verify licensing requirements with the original publisher (Elsevier Science / Pergamon Press) or the copyright holders. The copyright of the original publication rests with Elsevier B.V. No dedicated commercial testing kit is required to purchase or score the scale.

12. References

Barsky, A. J., & Wyshak, G. (1990). Hypochondriasis and somatosensory amplification. British Journal of Psychiatry, 157(3), 404–409. https://doi.org/10.1192/bjp.157.3.404

Greenough, C. G., & Fraser, R. D. (1991). Assessment of outcome in patients with low-back pain: The Modified Somatic Perception Questionnaire and the Distress and Risk Assessment Method. Spine, 16(2), 212–214. https://doi.org/10.1097/00007632-199102000-00018

Main, C. J. (1983). The Modified Somatic Perception Questionnaire (MSPQ). Journal of Psychosomatic Research, 27(6), 503–514. https://doi.org/10.1016/0022-3999(83)90041-6

Main, C. J., & Waddell, G. (1984). The detection of psychological distress in patients with low back pain using the Distress and Risk Assessment Method. Journal of Psychosomatic Research, 28(6), 481–488. https://doi.org/10.1016/0022-3999(84)90082-4

Main, C. J., Wood, P. L. R., Hollis, S., Spanswick, C. C., & Waddell, G. (1992). The Distress and Risk Assessment Method: A simple patient classification to identify distress and predict the outcome of low back pain. Spine, 17(1), 42–52. https://doi.org/10.1097/00007632-199201000-00007

Waddell, G., McCulloch, J. A., Kummel, E., & Venner, R. M. (1980). Nonorganic physical signs in low-back pain. Spine, 5(2), 117–125. https://doi.org/10.1097/00007632-198003000-00005

13. Items of the Scale (Questionnaire)